The influence of the glucose concentration in urines being assayed as part of a pancreolauryl test was investigated. Paired patient urines (n = 5) were assayed at 60" and 70 D C, before and after spiking to 5% glucose. The influence of assay temperature alone was assessed using glucose-free paired patient urines (n = 10). Aqueous glucose solutions and spiked (5% glucose) normal random urines (n = 5) were assayed to assess the effect of glucose concentration alone.
SUMMARY. The influence of the glucose concentration in urines being assayed as part of a pancreolauryl test was investigated. Paired patient urines (n = 5) were assayed at 60" and 70 D C, before and after spiking to 5% glucose. The influence of assay temperature alone was assessed using glucose-free paired patient urines (n = 10). Aqueous glucose solutions and spiked (5% glucose) normal random urines (n = 5) were assayed to assess the effect of glucose concentration alone.
There was no difference in T/K ratios for glucose-free patient samples at 60", 70°a nd 80 DC. After spiking with glucose T /K ratios were significantly different when assayed at 70 DC, but not when assayed at 60"C. Aqueous glucose solutions > 0·6% produced a pigment at temperatures ?: 65°C which absorbed at the }.max of fluorescein.
Glucose was found to interfere in the pancreolauryl test. Caution should be exercised when interpreting results from glucosuric samples.
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The pancreolauryl test [fluorescein dilaurate, FDL (Charwell Pharmaceuticals Ltd, Alton, UK)] is used in the investigation of the malabsorption syndrome to assess pancreatic exocrine function. I 3 Pancreatic enzymes hydrolyse oral fluorescein dilaurate releasing water soluble fluorescein which is freely absorbed in the small intestine and excreted in the urine as a mixture of free fluorescein and fluorescein glucuronides.v' A control dose of sodium fluorescein is given the following day and a fluorescein excretion index (T/K ratio) is calculated as a ratio of the percentage of the fluorescein dose excreted on the test day (T) to that excreted on the control day (K). During a routine pancreolauryl test assay in our department it was noted that a pair of urine samples from a particular patient had turned unusually dark in colour during analysis. These samples were found to come from a diabetic patient (patient X) and the glucose content of both was > 2% (> III rnmol/L) by Diastix [glucose oxidase reagent strip (Bayer Pic, Basingstoke, UK)].
Glucose interference in the pancreolauryl test is not a recognized problem, sulphasalazine and riboflavin" being the only reported interferences to date. We have investigated the effect of glucose in the pancreolauryl test and report evidence of glucose interference causing erroneous results.
MATERIALS AND METHODS

Reagents
Sodium hydroxide (NaOH) and glucose were obtained from BDH (Merck Ltd Poole, UK). Sodium fluorescein and fluorescein glucuronide were obtained from Sigma-Aldrich Co Ltd (Poole, UK). 
RESULTS
Glucose interference in the Pancreolauryl Test
Under the standardized hydrolysis conditions (lOmin, 70"C) aqueous glucose solutions of ;:::,0·6% gave measurable absorbance readings which increased with increasing glucose concentration. Prod uction of the absorbing species was temperature dependent ( Fig. I) .
When the paired patient samples were both spiked to 5% glucose the % dye excretion increased on average by 11·8 [42% of original value, standard deviation (SO) = 2,52]. The mean T/K ratio increased by 16·7 (68% of original value, SO = 3'66) and was significantly different to that calculated from the glucose-free samples (P= 0'001).
Of the five patients used in this part of the study the interpretation of the T/K ratio 
Analysis of results
Differences in group means were tested by Student t test for paired samples, P";; 0·05 was considered significant.
Assay imprecision
The overall between-run precision of the hydrolysis procedure was assessed using a QC solution containing a total of 0·185 mrnol/L fluorescein (0,106 mmol/L as sodium fluorescein and 0·079 mmol/l, as fluorescein glucuronide). The final concentration of the QC solution represents 37% of a 0·5 mmol oral fluorescein dose. Precision was assessed at 60°and 70"C.
Effect of glucose in the Pancreolauryl Test
Five pairs of patient pancreolauryl test samples and five random normal urine samples were assayed as normal at 70"C, then spiked to give a final concentration of 5% glucose and reassayed at 60" and 70"C. Aqueous solutions of glucose covering the range O' 2 -I O·OIYu were also assayed as urine samples and subjected to 'hydrolysis' at 60", 65 u , 70' and 80"C. Results for the aqueous glucose solutions and the normal control urines are expressed in a standardized form, i.e. apparent % dye excreted in a nominal urine vol ume of 2000 m L (the mean urine volume of the last 25 pancreolauryl tests sent to our department was 1930mL).
Effect of hydrolysis temperature
Ten pairs of patient urine samples were assayed at 60", 70" and 80 uC. The % dye excretion and the T/K ratios were calculated at each temperature to assess the effect on patient results. The effect of changing the assay temperature on the hydrolysis of fluorescein was investigated using aqueous solutions of sodium fluorescein (0' 106 mmol/L), and fluorescein glucuronide (0·079mml/L). A nominal volume of 1000mL was used to calculate an apparent % dye excretion for these and the quality control (QC) sample (below).
Urine samples
Fifteen consecutive paired patient urine samples (test and control days) sent to the laboratory as part of a pancreolauryl test were frozen after routine assay until required for the study. Random urine samples from five healthy laboratory workers were used as normal controls. All urines (patients and normals) were negative for glucose by Diastix. All assays were carried out in duplicate.
The assay of fluorescein in urine Urinary fluorescein is quantitated by direct spectrophotometric measurement at )'max = 492 nm (I:= 70 x 10 6 mL/mol) after a simple procedure to hydrolyse the lactone ring of fluoresccin.v" The hydrolysis procedure recommended by the test manufacturers requires dilution of the sample 1/10 with 0·( rnol/L NaOH and then heating at 65"-70"C for 10 min." To standardize our investigations we hydrolysed all samples at 70'C.
changed from 'equivocal' to 'normal exocrine function' in three patients, and from 'pancreatic insufficiency' to 'equivocal' in another patient. When the spiked samples were assayed at 60"C, the T/K ratios were not significantly different (P = 0'697) from those of the un spiked samples at 70°C and result interpretation was unchanged (Table I) .
The glucose-free normal urine samples gave very low absorbance readings and the mean apparent % dye excretion was 0·09. The spiked normal urines gave a mean apparent % dye excretion of 10·2 (SD = O'56) when assayed at 70°C and 0·28 (SD = 0·268) when assayed at 60°C. The magnitude of the effect of glucose in the normal urines was similar to that seen in the patient samples. The mean apparent % dye excretion calculated for fluorescein glucuronide (n = 10) was 6·8 at 70°C which was significantly different (P<O'OOI) from means of 5-4 and 7·6 at 60 and 70°C respectively. The recoveries of fluorescein from fluorescein glucuronide after hydrolysis at 60°, 70°and 80°C were 34%, 43% and 48%, respectively.
Assay imprecision
The imprecision of the whole assay was tested at 60°and 70°C using the mixed QC solution. The coefficient of variation (CY) at 70°C = 2.4% (mean = 28·3, n = 10). The CY at 60°C = 1·6% (mean = 26·8, n = 9). I  23·2  34·9  21·3  2  23·0  39·2  25·2  3  39·4  63·0  41·8  4  29·2  42-3  28·1  5 7·7 26·7 7·9
Hydrolysis of fluorescein
There was no change in the molar absorption or the apparent % dye excretion of the sodium fluorescein solution (n = 10) after hydrolysis at 60°C (mean = 21,6) compared to that at 70°C (x=21'4) (P=0.566) or 80°C (mean = 21.5) (P = O' 585). The mean recovery of fluorescein at all temperatures was 101%.
Changing hydrolysis temperature
Assaying patient samples at different temperatures resulted in significant changes to the % dye excretion whereas the T/K ratios were unaffected. The mean % dye excretion increased by 4·8 (18·9%, SD = 2-40) between 60°and 70°C (P<O·OOI), and by 3·3 (10,9%, SD=2·16) between 70°and 80°C [P<O'OOI ( Fig. 2) ]. There were no significant differences in T/K ratios between 60°and 70°C (P=0'691) or 70°and 80°C (P= 0-495) and result interpretation was unaffected ( Fig. 3) . 
DISCUSSION
In the pancreolauryl test, glucosuric urines can give misleading results. The apparent increase in the % dye excretion due to the presence of glucose can have a dramatic effect on the T /K ratio and on the interpretation of results. The magnitude of the effect will depend on the concentration of glucose present, the urine volume and on whether both or only one of the specimens contain significant concentrations of glucose. Urine samples from healthy individuals usually have very little pigment that absorbs at 492 nm (the )'ma, for fluorescein). Solutions of glucose (aqueous or in urine), when treated by the recommended hydrolysis procedure, produce a yellow-brown pigment which has a broad absorption peak stretching from the ultraviolet range to approximately 560 nm, peaking at 298 nm and with a molar extinction coefficient at 492 nm of 6·8. This colour is not produced when the hydrolysis solutions are incubated at room temperature or if the samples are incubated at 70°C in water rather than 0·1 rnol/L NaOH. The pigment is probably caramel which is produced by heating glucose in the presence of weak alkali."
Pancreatic disease often affects endocrine secretions as well as exocrine and can present with glucose intolerance." Analysis by Diastix of 25 consecutive pancreolauryl tests (50 urine samples) arriving in this laboratory showed nine samples (18%), from five patients (20%), to contain > I% glucose (three samples contained > 2% glucose). The incidence of glycosuria in patients being investigated for possible pancreatic exocrine insufficiency should warrant concern when the presence of glucose in the urine can cause falsely high or low results. The original T/K ratio for patient X at 70°C was 29·0%. When the same samples were reassayed at 60"C the T/K ratio was 12·2%.
Changing the hydrolysis temperature to 60°C minimized the interference due to glucose, and appeared to have little or no effect on the final result. Interpretation of the T/K ratio was the same at 60°and 70°C for each of the 10 patients.
Free fluorescein is easily hydrolysed at 60°C and indeed hydrolysis of a 0·106 mrnol/L solution is complete after 5 min at room temperature (data not shown). Conjugation by glucuronide renders the fluorescein ring much more resistant to hydrolysis hence heating is req uired. Complete hydrolysis of the control solution of fluorescein glucuronide (0,079 mmol/ L) was not achieved under the conditions studied. This concentration represents 43% conjugation of an excreted amount of 37% of that administered as dilaurate, values which approximately reflect normality."
Despite incomplete hydrolysis of fluorescein, it appears that the relative amount of hydrolysis in the test and control urines are similar at a particular temperature so that the T/K ratio is apparently unaffected by changing the assay temperature. An alternative hydrolysis procedure that avoids interference due to glucose would be of benefit. Lowering the temperature of hydrolysis is one approach worthy of further investigation.
We recommend that all urines for the pancreolauryl test are screened for glycosuria prior to assay. Results from urines containing >2% glucose should be interpreted with caution if the current recommended assay conditions are used.
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COMMENT FROM TEMMLER PHARMA
The Pancreolauryl-Test N (PL T) is a diagnostic tool suitable for detection and staging disorders of the exocrine pancreas, which has been in use for many years. Many studies have proved its high scientific rank.
The test is based on the administration of fluorescein dilaurate, a specific substrate of the pancreatic enzyme cholesterol esterase, which releases fluorescein. The amount of fluorescene measured in the urine or serum depends on the quantity of cholesterol esterase produced and secreted by the exocrine pancreas.
Because the PL T is an indirect method, it is not possible to discriminate primary pancreas diseases (for example chronic pancreatitis) or secondary pancreas diseases such as patients who have undergone surgery of the stomach (Billroth I + II operations), or in patients with Crohn's disease, sprue or jaundice.
The sensitivity and specificity of the urine-PLT is very high (82% and 90%}---the serum-PL T also has a high sensitivity and specificity of Trewick 82% and 91 % as shown in a recent study of Dominguez-Mufios et a/. IO The PL T is very easy to carry out, and has been registered and used in Germany since 1978.
High doses of vitamin 8 2 or drugs which promote intestinal passage may interfere with the PL T. The interference of glucose in the PLT, which has been reported in the Trewick study, was never observed before.
Temmler Pharma therefore repeated the studies mentioned in this study and there is indeed a slight interference of glucose with the PLT. The level of interference is very low and is not likely to have a negative effect on the sensitivity and specificity of the PLT for the following reasons:
The interference of glucose in urine depends on its concentration, so that high glucose concentrations increase the interference. A noticeable interference can only be observed if the glucose concentration in the urine is higher than 2 gj 100 mL. This will occur only in very few cases. This must be the reason, why this effect has never been observed before during the many years of use of PLT in different countries 2 Temmler Pharma also checked if the serum-PL T (which was not studied by the authors) was similarly affected by different glucose levels in serum. Glucose concentrations over 250 mgjlOOmL (l4mmoljL) were found to have a noticeable effect 3
Accordingly, in diabetic patients, glucose levels should be near normal before testing 4
Serum-PLT and urine-PLT have a very high sensitivity and specificity. A relevant effect of interference through glucose would lower sensitivity and specificity of the PL T Nevertheless Temmler Pharma as a responsible manufacturer of drugs and diagnostics has added the following notice in the section 'interactions with other drugs' in the SPC of the PLT:
Ann cu« Biochem 1998: 35
When using the Pancreolauryl-Test N in diabetic patients it must be ascertained, that the blood sugar is within the normal range, because in certain conditions the test result can be distorted by abnormal high glucose concentration in serum and urine, respectively.
We therefore recommend that all doubtful patients be checked, measuring blood sugar levels and checking whether glucosuria is significant, beforehand.
